Daily Respiratory Research Analysis
Analyzed 58 papers and selected 3 impactful papers.
Summary
Three high-impact respiratory studies span mechanistic biology, early cancer detection, and imaging phenotypes in vasculitis. A Nature Communications multicohort analysis links an axon-guidance endotype in SGA newborns to later spirometric restriction. A UK Biobank proteomic study builds a dynamic 28-protein signature for prediagnostic lung cancer risk, while a Japanese cohort delineates distinct HRCT patterns by ANCA subtype in AAV.
Research Themes
- Early-life molecular endotypes shaping lung development and function
- Dynamic proteomic biomarkers for prediagnostic lung cancer risk stratification
- Imaging phenotypes linked to ANCA subtypes in vasculitis-associated lung disease
Selected Articles
1. Multicohort analysis unveils axon guidance pathways linking small for gestational age to spirometric restriction.
Across multiple birth cohorts, about one-third of SGA newborns showed a cord-blood endotype characterized by dysregulated axon-guidance proteins. These signals inversely tracked with later spirometric restriction, and convergent support from GWAS and a sheep model linked axon-guidance genes to spirometric indices.
Impact: This study proposes a mechanistic link between neurodevelopmental pathways and pulmonary development, redefining how early-life growth restriction imprints long-term lung function.
Clinical Implications: Identifying an axon-guidance molecular endotype in SGA infants could enable early risk stratification and surveillance for restrictive ventilatory impairment, informing preventive strategies.
Key Findings
- Approximately one-third of SGA children exhibit a cord-blood molecular endotype featuring dysregulated axon-guidance proteins.
- Later-life peripheral blood levels of these proteins inversely associate with spirometric restriction.
- GWAS and an experimental sheep model provide convergent evidence linking axon-guidance genes to spirometric indices.
Methodological Strengths
- Multicohort human proteomic analysis spanning birth and later life.
- Triangulation with GWAS and an in vivo sheep model to support causality.
Limitations
- Causality remains inferential despite genetic and animal-model triangulation.
- Generalizability beyond the included cohorts and populations requires validation.
Future Directions: Prospective validation of the axon-guidance endotype in diverse populations and interventional studies to test modifiable pathways influencing lung growth.
Children born small for gestational age (SGA) face elevated risks of metabolic, cardiovascular, respiratory, and neurodevelopmental disorders, as well as premature mortality, yet the underlying mechanisms remain only partly understood. We analyze blood proteomic data from multiple birth cohorts to identify molecular pathways linked to SGA and to later-life lung function. We find that approximately one-third of SGA children exhibit a distinct molecular endotype marked by dysregulation of axon-guidance proteins in cord blood. In peripheral blood collected later in life, these proteins are inversely associated with contemporaneous spirometric restriction. Using GWAS data and an experimental sheep model, we obtain convergent evidence that axon-guidance genes are associated with spirometric indices (FEV
2. A dynamic proteomic signature for the prediction of lung Cancer: a longitudinal analysis in the UK Biobank cohort.
In 37,759 UK Biobank participants, 340 proteins showed time-varying associations with lung cancer risk, revealing a molecular timeline from cell-adhesion dysregulation to inflammatory surges pre-diagnosis. A 28-protein signature, combined with clinical factors and PRS, achieved an AUC of 0.83 and Mendelian randomization implicated causal roles for select proteins.
Impact: This work delineates the prediagnostic biology of lung cancer and delivers a high-performing proteomic signature that could complement imaging for risk-adapted screening.
Clinical Implications: A validated proteomic risk tool could refine selection and timing for low-dose CT screening and enable earlier interventions in individuals with active progression signals.
Key Findings
- Identified 340 risk-associated proteins with distinct temporal trajectories before lung cancer diagnosis.
- Early (>5 years) risk linked to CEACAM5; imminent (<5 years) risk marked by IL-6 and inflammatory proteins.
- A 28-protein signature plus clinical factors and PRS achieved AUC 0.830; MR suggested causal roles for select proteins.
Methodological Strengths
- Large, prospective cohort with long follow-up and extensive proteomic coverage.
- Use of time-stratified modeling, multi-algorithm ML, and Mendelian randomization.
Limitations
- Generalizability outside UK Biobank requires external validation.
- Assay/platform harmonization and clinical workflow integration remain to be addressed.
Future Directions: External validation across diverse populations and prospective implementation studies assessing integration with LDCT and risk-adapted intervention pathways.
BACKGROUND: To understand the molecularly obscure pre-diagnostic phase of lung cancer, we mapped the temporal evolution of the plasma proteome for new biological insights and improved risk prediction. METHODS: Leveraging the UK Biobank prospective cohort, we analyzed 2,921 plasma proteins from 37,759 participants, including 342 incident lung cancer cases identified over a median follow-up of 11.7 years. We employed time-stratified Cox models, locally weighted scatterplot smoothing (LOESS) trajectory modeling, and hierarchical clustering to characterize protein dynamics relative to the time of diagnosis. A multi-algorithm machine learning pipeline was used to develop a predictive signature, and two-sample Mendelian randomization was performed to infer causal relationships. RESULTS: We identified 340 risk-associated proteins showing significant temporal heterogeneity. Long-term risk (>5 years pre-diagnosis) was linked to proteins like CEACAM5, indicating early dysregulation of cell adhesion. Imminent risk (<5 years) was marked by a surge in inflammatory proteins like IL6. These dynamics were resolved into four distinct trajectory patterns, creating a molecular timeline of carcinogenesis. A machine learning-derived 28-protein signature, integrated with clinical factors and Polygenic Risk Score (PRS), achieved outstanding predictive performance (AUC = 0.830). Mendelian randomization also suggested a causal role for some proteins of 340 risk-associated proteins in lung cancer development. CONCLUSION: Our findings establish that lung cancer evolves through a dynamic sequence of protein changes. This provides a new model for understanding pre-diagnostic disease, and our 28-protein signature is a powerful tool for precision screening to identify individuals with active disease progression.
3. Differences in chest HRCT findings in relation to ANCA subtypes in ANCA-associated vasculitis.
In 195 Japanese AAV patients, MPO-ANCA positivity was associated with interstitial pneumonia—particularly definite UIP—whereas PR3-ANCA positivity showed more nodules and cavities. HRCT abnormalities were common (88%), underscoring distinct pulmonary phenotypes by ANCA subtype.
Impact: Differential HRCT phenotypes by ANCA subtype refine diagnostic suspicion and may inform tailored monitoring and therapy in AAV-related lung disease.
Clinical Implications: MPO-ANCA patients warrant vigilant screening for UIP-pattern ILD, while PR3-ANCA patients may require focused evaluation for nodules/cavities and infectious or vasculitic complications.
Key Findings
- HRCT abnormalities were present in 172/195 patients (88%).
- MPO-ANCA positivity associated with higher rates of interstitial pneumonia and definite UIP pattern (41% vs 0%).
- PR3-ANCA positivity associated with more nodules (44%) and cavities (33%) compared to MPO-ANCA.
Methodological Strengths
- Analysis within a national observational cohort with standardized diagnostic-time HRCT.
- Direct comparison across defined ANCA subtypes with statistical testing.
Limitations
- Retrospective observational design limits causal inference.
- Reader variability and lack of longitudinal outcome correlation were not addressed.
Future Directions: Prospective studies linking HRCT phenotypes by ANCA subtype to prognosis and treatment response, and validation in non-Japanese cohorts.
BACKGROUND: Differences in chest HRCT findings between myeloperoxidase (MPO)- antineutrophil cytoplasmic antibody (ANCA) and proteinase 3 (PR3)-ANCA in Japanese patients with ANCA-associated vasculitis (AAV) remain unclear. METHODS: We reviewed chest HRCT findings at diagnosis in 195 patients with AAV enrolled in the Remission Induction Therapy in Japanese Patients with ANCA-associated Vasculitis and Rapidly Progressive Glomerulonephritis (RemIT-JAV-RPGN) observational cohort study (2011-2013). Findings were classified by ANCA subtype and compared. RESULTS: Abnormal chest HRCT findings were observed in 172 of 195 patients. Main findings included ground-glass opacity (n = 92, 47%), reticulation (n = 79, 41%), traction bronchiectasis (n = 67, 34%), and honeycombing (n = 4 9, 25%). Honeycombing (n = 46, 29%) and reticulation (n = 70, 43%) predominated in patients with positive MPO-ANCA, whereas nodules (n = 4, 44%) and cavities (n = 3, 33%) were more frequent in those with positive PR3-ANCA. Interstitial pneumonia (IP) was diagnosed in 89 patients, with HRCT patterns of definite usual interstitial pneumonia (UIP) in 31 (35%), possible UIP in 22 (25%), and inconsistent with UIP in 36 (40%). IP was more frequent in patients with positive MPO-ANCA than in those with positive PR3-ANCA (47% vs 11%, respectively; p = 0.003). Definite UIP was more common in MPO-ANCA positivity than in other subtypes (41% vs 0%, respectively; p = 0.023). CONCLUSIONS: In Japanese patients with AAV, IP with a definite UIP pattern was more frequent in patients with MPO-ANCA positivity while nodules and cavities were more frequent in patients with positive PR3-ANCA.